OptiBiotix Health PLC (OPTI)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
5.70p
Buy
6.20p
0.00p (+0.00%)
Prices updated at 19 Jun 2026, 16:22 BST
| Prices minimum 15 mins delay
Prices in GBX
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Richard Colin Neil Davidson CBE
CEO
Mr. Stephen Patrick O'Hara
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
9
Head office
Innovation Centre, Innovation Way
York
United Kingdom
YO10 5DG
Key personnel
Owner name | Salary |
|---|---|
Mr. Richard Colin Neil Davidson CBE Non-Executive Director, Chairman | - |
Mr. Michael Sean Christie Non-Executive Director | - |
Dr. Sofia Kolyda Executive Director, Research and Development Director | - |
Mr. David Jonathan Blain Executive Director, Finance Director and Company Secretary | - |
Mr. Stephen Patrick O'Hara Executive Director, Chief Executive Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| No data | |
Director dealings
Date | Action |
|---|---|
| 28 May 2026 | Purchase |
| 01 Oct 2025 | Purchase |
| 23 Sep 2025 | Purchase |
| 23 Sep 2025 | Purchase |
| 22 Sep 2025 | Purchase |
| 22 Sep 2025 | Purchase |
Please note that past performance is not a reliable indicator of future returns.